2012 Q2/Global Life Sciences


Summary

Full results


Rank Chg Organisation name Overall
1 +0 Cilag AG
8.7
2 +0 Anergis
8.5
3 +0 Siegfried AG
8.2
4 +1 Lumavita AG
8.1
5 +0 Salmon Pharma GmbH
8.0
6 -2 Piramal Healthcare
7.6
7 +16 4-Antibody AG
7.6
8 +0 Eisai (company)
7.6
9 +86 NovImmune
7.5
10 +2 Redbiotec AG
7.4
11 +2 Newron Suisse SA
7.3
12 +3 Neurimmune Therapeutics AG
7.3
13 -2 Kuros Biosurgery AG
7.3
14 +0 Pharmakon Ltd.
7.2
15 -8 Medinova AG
7.2
16 +45 Acino Holding AG
7.2
17 +0 Gebro Pharma AG
7.2
18 -1 Celgene
7.1
19 -13 Actelion Ltd.
7.1
20 -11 Max Zeller Söhne AG
7.0
21 +0 Wockhardt
6.9
22 +122 LEO Pharmaceutical Products Sarath Ltd.
6.9
23 -5 Neurim Pharmaceuticals S.A.
6.8
24 +5 Intercytex
6.7
25 +2 Renovo
6.6
26 +36 Tillotts Pharma AG
6.6
27 +0 Sandoz Pharmaceuticals AG
6.5
28 +2 MEDA Pharma GmbH
6.4
29 +6 Helvepharm AG
6.4
30 +12 STADA Arzneimittel
6.3
31 -9 Astellas Pharma
6.3
32 +0 BioPartners GmbH
6.3
33 +1 Tricom GmbH, Pharma Division
6.3
34 +16 Lundbeck (Schweiz) AG
6.3
35 +97 Ego Pharmaceuticals
6.3
36 +1 Nycomed International Management GmbH
6.2
37 +1 GKL Biotec AG
6.2
38 +0 Astellas Pharma AG
6.2
39 -6 Virbac Schweiz AG
6.1
40 -24 Biogen Idec International GmbH
6.1
41 +0 Allergan UK
6.1
42 +0 Sanofi-Aventis UK
6.1
43 +16 Evolva SA
6.0
44 -1 OMIDA AG
6.0
45 +0 Sanofi-Aventis (Schweiz) AG
6.0
46 -6 Aptalis
5.9
47 -1 Octapharma AG
5.9
48 +9 Molecular Partners
5.9
49 -2 Lipideon Biotechnology AG
5.9
50 +3 Nectar Lifesciences
5.9


Changes in rank are compared to 2012 Q1/Global Life Sciences. Since then, 16 sites entered the survey and 17 sites could not be included in the rankings (same since last). Build your own. Report statistics.